A SECRET WEAPON FOR WHO MAKES COPYRIGHT

U.S. pharma giant copyright scrapped two experimental weight loss capsules last yr—a once-each day tablet, lotiglipron, resulting from elevated liver enzymes and a twice-each day pill, danuglipron, resulting from potent Unintended effects—but CEO Albert Bourla has explained the company is set to “Participate in and acquire” from the obesity